Trial Profile
Telaprevir or boceprevir in HIV/HCV-1 co-infected patients in a real-life setting. COINFECOVA-SEICV study
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Sep 2015
Price :
$35
*
At a glance
- Drugs Boceprevir (Primary) ; Telaprevir (Primary) ; Peginterferon alfa-2a; Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms COINFECOVA-SEICV
- 16 Sep 2015 New trial record